Dalle Carbonare, L. et al. 2009. Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project. Reumatismo. 61, 1 (Mar. 2009), 54–64. DOI:https://doi.org/10.4081/reumatismo.2009.54.